Significant Ownership of Bellevue Group AG
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Bellevue Group AG focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Stefano Montalbano - Stefano Montalbano/ Chief Financial Officer
- Manager location
- Zurich
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Bellevue Group AG and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Bellevue Group AG
Significant Ownership of Bellevue Group AG
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | Common Stock | 6.8% | $46,307,688 | 3,341,103 | Bellevue Group AG | 16 Dec 2025 | ||
| VRDN | Viridian Therapeutics, Inc. | Common Stock | 6.6% | $93,493,402 | 6,726,144 | Bellevue Group AG | 31 Mar 2026 | ||
| IMCR | Immunocore Holdings plc | Ordinary shares | 5.6% | $101,607,853 | 2,796,803 | Bellevue Group AG | 20 Aug 2025 | ||
| CLDX | Celldex Therapeutics, Inc. | Common Stock | 1.5% | $37,512,000 | -$75,576,333 | 1,200,000 | -67% | Bellevue Group AG | 31 Mar 2026 |
| MGNX | MacroGenics, Inc. | Common Stock | 0% | $0 | -$13,901,948 | 0 | -100% | Bellevue Group AG | 05 Dec 2025 |
| AGIO | Agios Pharmaceuticals, Inc. | Common Stock | 0% | $0 | -$142,398,726 | 0 | -100% | Bellevue Group AG | 19 Nov 2025 |
Schedules 13D/G Reported by Bellevue Group AG:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.